Aquestive Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03843E1047

SecurityAQST / Aquestive Therapeutics, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership2,546,191 shares
Latest Disclosed Value $ 10,566,693
State Street Corp reports 3.39% increase in ownership of AQST / Aquestive Therapeutics, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 2,546,191 shares of Aquestive Therapeutics, Inc. (US:AQST) valued at $10,566,693 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,462,778 shares of Aquestive Therapeutics, Inc.. This represents a change in shares of 3.39% during the quarter. The current value of the position is $10,541,231 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 2,546,191 83,413 3.39 10,567 -33.58 0.0004
2026-02-13 2025-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 2,462,778 860,562 53.71 15,910 77.64 0.0005
2025-11-14 2025-09-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 1,602,216 94,918 6.30 8,956 79.51 0.0003
2025-08-14 2025-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 1,507,298 -15,357 -1.01 4,989 13.00 0.0002
2025-05-15 2025-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 1,522,655 18,764 1.25 4,416 -17.52 0.0002
2025-02-14 2024-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 1,503,891 7,152 0.48 5,354 -28.18 0.0002
2024-11-14 2024-09-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 1,496,739 512,682 52.10 7,454 191.36 0.0003
2024-08-14 2024-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 984,057 802,420 441.77 2,559 230.92 0.0001
2024-05-15 2024-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 181,637 30,100 19.86 774 152.61 0.0000
2024-02-14 2023-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 151,537 14,200 10.34 306 45.71 0.0000
2023-11-14 2023-09-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 137,337 0 0.00 210 -7.08 0.0000
2023-08-14 2023-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 137,337 41,300 43.00 227 107.34 0.0000
2023-05-15 2023-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 96,037 0 0.00 109 26.74 0.0000
2023-05-15 2022-12-31 13F/A-99 AQUESTIVE THERAPEUTICS COM 03843E104 96,037 0 0.00 87 -23.21 0.0000
2023-05-15 2022-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 96,037 0 87 0.0000
2022-11-15 2022-09-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 96,037 0 0.00 112 83.61 0.0000
2022-08-15 2022-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 96,037 0 0.00 61 -75.70 0.0000
2022-05-16 2022-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 96,037 8,960 10.29 251 -25.96 0.0000
2022-02-14 2021-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 87,077 17,200 24.61 339 11.15 0.0000
2021-11-15 2021-09-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 69,877 0 0.00 305 10.11 0.0000
2021-08-16 2021-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 69,877 -253,766 -78.41 277 -83.54 0.0000
2021-07-09 2021-03-31 13F/A-1 AQUESTIVE THERAPEUTICS COM 03843E104 323,643 8,752 2.78 1,683 -0.12 0.0001
2021-05-17 2021-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 323,643 8,752 1,683 0.0001
2021-02-16 2020-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 314,891 25,047 8.64 1,685 19.76 0.0001
2020-11-10 2020-09-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 289,844 1,114 0.39 1,407 0.29 0.0001
2020-08-14 2020-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 288,730 288,730 1,403 0.0001
2019-08-14 2019-06-30 13F AQUESTIVE THERAPEUTICS COM 03843E104 0 -48,935 -100.00 0 -100.00
2019-05-15 2019-03-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 48,935 6,355 14.92 338 26.12 0.0000
2019-02-12 2018-12-31 13F AQUESTIVE THERAPEUTICS COM 03843E104 42,580 27,780 187.70 268 3.08 0.0000
2018-11-09 2018-09-30 13F AQUESTIVE THERAPETC Common Stock 03843E104 14,800 14,800 260 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.